Interv Akut Kardiol. 2023;22(3):145-150 | DOI: 10.36290/kar.2023.022

Technology of catheter ablation of atrial fibrillation using pulsed field

Martin Mudroch, Štěpán Královec, Jan Petrů, Petr Neužil
Nemocnice Na Homolce, Praha

Catheter ablation of atrial fibrillation using radiofrequency energy has been the gold standard until these days. Nevertheless, there are limitations associated with the application of thermal energy such as damage to collateral structures, time-consuming nature, and, in particular, frequent recurrences of both atrial fibrillation and atrial tachycardias. Therefore, it was essential to find a brand new method with a better safety and efficiency profile. Promising results have been obtained with methods using pulsed field based on the principles of irreversible electroporation which, in comparison with the methods used so far that have a thermal effect and induce coagulation necrosis, predominantly cause disintegration of the cell membrane. This article deals with the principle of electroporation, pathophysiological background, and technical specification of the development of ablation systems using pulsed field energy. Also presented are the results of initial clinical trials with ablation treatment of all types of atrial fibrillation using the pulsed field method as well as the initial experience from the practice.

Keywords: atrial fibrillation, catheter ablation, electroporation, pulsed field ablation.

Received: March 3, 2023; Revised: May 4, 2023; Accepted: May 11, 2023; Published: November 7, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mudroch M, Královec Š, Petrů J, Neužil P. Technology of catheter ablation of atrial fibrillation using pulsed field. Interv Akut Kardiol. 2023;22(3):145-150. doi: 10.36290/kar.2023.022.
Download citation

References

  1. Zulkifly H, Lip GYH, Lane DA. Epidemiology of atrial fibrillation. Int J Clin Pract. 2018;72(3):e13070. Go to original source... Go to PubMed...
  2. Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139(10):e56-528. Go to original source... Go to PubMed...
  3. Miloš Táborský, Martin Fiala, Petr Heinc, et al. Fibrilace síní: doporučený diagnostický a terapeutický postup pro všeobecné praktické lékaře 2021. Praha: Společnost všeobecného lékařství ČLS JEP; (Centrum doporučených postupů pro praktické lékaře).
  4. Čihák R. Registr katetrizačních ablací pro arytmie ČR 2018 [Internet]. XXVII. VÝROČNÍ SJEZD ČKS; 2019; Brno. Available from: https://www.kardio­‑cz.cz/data/clanek/1082/dokumenty/registr­‑cr­‑ablace-2018.pdf
  5. Čihák R. KATAB - Analytická zpráva a přehled stavu registru za rok 2021. XIX. Slovenské a české sympózium o arytmiách a kardiostimulácií 2022; 2022; Tále, Slovenská Republika.
  6. Reddy VY, Grimaldi M, De Potter T, et al. Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature­‑Controlled Lesions: The QDOT­‑FAST Trial. JACC Clin Electrophysiol. 2019;5(7):778-86. Go to original source... Go to PubMed...
  7. Andrade JG. Cryoballoon ablation for pulmonary vein isolation. J Cardiovasc Electrophysiol. 2020;31(8):2128-35. Go to original source... Go to PubMed...
  8. Tohoku S, Bordignon S, Bologna F, et al. Laser balloon in pulmonary vein isolation for atrial fibrillation: current status and future prospects. Expert Rev Med Devices. 2021;18(11):1083-91. Go to original source... Go to PubMed...
  9. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14(10):e275-444. Go to original source... Go to PubMed...
  10. Tsao HM, Wu MH, Higa S, et al. Anatomic relationship of the esophagus and left atrium: implication for catheter ablation of atrial fibrillation. Chest. 2005;128(4):2581-7. Go to original source... Go to PubMed...
  11. Singh SM, d'Avila A, Singh SK, et al. Clinical outcomes after repair of left atrial esophageal fistulas occurring after atrial fibrillation ablation procedures. Heart Rhythm. 2013;10(11):1591-7. Go to original source... Go to PubMed...
  12. Weaver JC. Electroporation of cells and tissues. IEEE Transactions on Plasma Science. 2000;28(1):24-33. Go to original source...
  13. Krassowska W, Filev PD. Modeling Electroporation in a Single Cell. Biophysical Journal. 2007;92(2):404-17. Go to original source... Go to PubMed...
  14. Ziegler MJ, Vernier PT. Interface Water Dynamics and Porating Electric Fields for Phospholipid Bilayers. The Journal of Physical Chemistry B. 2008;112(43):13588-96. Go to original source... Go to PubMed...
  15. Vernier PT, Ziegler MJ. Nanosecond Field Alignment of Head Group and Water Dipoles in Electroporating Phospholipid Bilayers. The Journal of Physical Chemistry B. 2007;111(45):12993-6. Go to original source... Go to PubMed...
  16. Novickij V, Dermol J, Grainys A, et al. Membrane permeabilization of mammalian cells using bursts of high magnetic field pulses. PeerJ. 2017;5:e3267. Go to original source... Go to PubMed...
  17. Chen C, Evans JA, Robinson MP, et al. Electroporation of cells using EM induction of ac fields by a magnetic stimulator. Physics in Medicine & Biology. 2010;55(4):1219. Go to original source... Go to PubMed...
  18. Guo F, Yao C, Bajracharya C, et al. Simulation study of delivery of subnanosecond pulses to biological tissues with an impulse radiating antenna: Delivery of Subnanosecond Pulses to Tissues. Bioelectromagnetics. 2014;35(2):145-59. Go to original source... Go to PubMed...
  19. Okino M, Mohri H. Effects of a high­‑voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jpn J Cancer Res. 1987;78(12):1319-21.
  20. Maor E, Sugrue A, Witt C, et al. Pulsed electric fields for cardiac ablation and beyond: A state­‑of­‑the­‑art review. Heart Rhythm. 2019;16(7):1112-20. Go to original source... Go to PubMed...
  21. Rubinsky B. Irreversible Electroporation. 1st ed. Vol. 2010. Berlin: Springer­‑Verlag; Go to original source...
  22. Maor E, Ivorra A, Rubinsky B. Non Thermal Irreversible Electroporation: Novel Technology for Vascular Smooth Muscle Cells Ablation. Reitsma PH, editor. PLoS ONE. 2009;4(3):e4757. Go to original source... Go to PubMed...
  23. Bao N, Le TT, Cheng JX, et al. Microfluidic electroporation of tumor and blood cells: observation of nucleus expansion and implications on selective analysis and purging of circulating tumor cells. Integr Biol (Camb). 2010;2(2-3):113-20. Go to original source... Go to PubMed...
  24. Sano MB, Neal RE, Garcia PA, et al. Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion. BioMedical Engineering OnLine. 2010;9(1):83. Go to original source... Go to PubMed...
  25. Li W, Fan Q, Ji Z, et al. The Effects of Irreversible Electroporation (IRE) on Nerves. Ulasov I, editor. PLoS ONE. 2011;6(4):e18831. Go to original source... Go to PubMed...
  26. Wittkampf FHM, van Driel VJ, van Wessel H, et al. Myocardial lesion depth with circular electroporation ablation. Circ Arrhythm Electrophysiol. 2012;5(3):581-6. Go to original source... Go to PubMed...
  27. Kaminska I, Kotulska M, Stecka A, et al. Electroporation­‑induced changes in normal immature rat myoblasts (H9C2). Gen Physiol Biophys. 2012;31(1):19-25. Go to original source... Go to PubMed...
  28. Arena CB, Szot CS, Garcia PA, et al. A three­‑dimensional in vitro tumor platform for modeling therapeutic irreversible electroporation. Biophys J. 2012;103(9):2033-42. Go to original source... Go to PubMed...
  29. du Pré BC, van Driel VJ, van Wessel H, et al. Minimal coronary artery damage by myocardial electroporation ablation. Europace. 2013;15(1):144-9. Go to original source... Go to PubMed...
  30. Miklavcic D, Davalos RV. Electrochemotherapy (ECT) and irreversible electroporation (IRE) -advanced techniques for treating deep­‑seated tumors based on electroporation. Biomed Eng Online. 2015;14 Suppl 3(Suppl 3):I1. Go to original source... Go to PubMed...
  31. Batista Napotnik T, Polajžer T, Miklavčič D. Cell death due to electroporation - A review. Bioelectrochemistry. 2021;141:107871. Go to original source... Go to PubMed...
  32. Sale AJH, Hamilton WA. Effects of high electric fields on microorganisms: I. Killing of bacteria and yeasts. Biochimica et Biophysica Acta (BBA) - General Subjects. 1967;148(3):781-8. Go to original source...
  33. Davalos RV, Mir LM, Rubinsky B. Tissue Ablation with Irreversible Electroporation. Annals of Biomedical Engineering. 2005;33(2):223-31. Go to original source... Go to PubMed...
  34. Lavee J, Onik G, Mikus P, et al. A novel nonthermal energy source for surgical epicardial atrial ablation: irreversible electroporation. Heart Surg Forum. 2007;10(2):E162-167. Go to original source... Go to PubMed...
  35. Wittkampf FH, van Driel VJ, van Wessel H, et al. Feasibility of electroporation for the creation of pulmonary vein ostial lesions. J Cardiovasc Electrophysiol. 2011;22(3):302-9. Go to original source... Go to PubMed...
  36. Kourounis G, Paul Tabet P, Moris D, et al. Irreversible electroporation (Nanoknife® treatment) in the field of hepatobiliary surgery: Current status and future perspectives. J BUON. 2017;22(1):141-9.
  37. Davalos RV, Mir ILM, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33(2):223-31. Go to original source... Go to PubMed...
  38. Reddy VY, Koruth J, Jais P, et al. Ablation of Atrial Fibrillation With Pulsed Electric Fields: An Ultra­‑Rapid, Tissue­‑Selective Modality for Cardiac Ablation. JACC Clin Electrophysiol. 2018;4(8):987-95. Go to original source... Go to PubMed...
  39. Reddy VY, Neuzil P, Koruth JS, et al. Pulsed Field Ablation for Pulmonary Vein Isolation in Atrial Fibrillation. J Am Coll Cardiol. 2019;74(3):315-26. Go to original source... Go to PubMed...
  40. Reddy VY, Dukkipati SR, Neuzil P, et al. Pulsed Field Ablation of Paroxysmal Atrial Fibrillation: 1-Year Outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol. 2021;7(5):614-27. Go to original source... Go to PubMed...
  41. Reddy VY, Anic A, Koruth J, et al. Pulsed Field Ablation in Patients With Persistent Atrial Fibrillation. J Am Coll Cardiol. 2020;76(9):1068-80. Go to original source... Go to PubMed...
  42. Ekanem E, Reddy VY, Schmidt B, et al. Multi­‑national survey on the methods, efficacy, and safety on the post­‑approval clinical use of pulsed field ablation (MANIFEST­‑PF). Europace. 2022;24(8):1256-66. Go to original source... Go to PubMed...
  43. Reddy VY, Petru J, Funasako M, et al. Coronary Arterial Spasm During Pulsed Field Ablation to Treat Atrial Fibrillation. Circulation. 2022;146(24):1808-19. Go to original source... Go to PubMed...
  44. Anter E, Neužil P, Rackauskas G, et al. A Lattice­‑Tip Temperature­‑Controlled Radiofrequency Ablation Catheter for Wide Thermal Lesions. JACC: Clinical Electrophysiology. 2020;6(5):507-19. Go to original source... Go to PubMed...
  45. Lattice­‑Tip Focal Ablation Catheter That Toggles Between Radiofrequency and Pulsed Field Energy to Treat Atrial Fibrillation: A First­‑in­‑Human Trial. Vol. 13. United States; 2020. Go to original source...
  46. Yavin HD, Higuchi K, Younis A, et al. Lattice­‑tip catheter for single­‑shot pulmonary vein isolation with pulsed field ablation. J Interv Card Electrophysiol. 2022; Go to original source... Go to PubMed...
  47. Musikantow DR, Neuzil P, Petru J, et al. Pulsed Field Ablation to Treat Atrial Fibrillation: Autonomic Nervous System Effects. JACC Clin Electrophysiol. 2022;S2405-500X(22)00943-4.
  48. Stojadinović P, Wichterle D, Peichl P, et al. Autonomic Changes Are More Durable After Radiofrequency Than Pulsed Electric Field Pulmonary Vein Ablation. JACC Clin Electrophysiol. 2022;8(7):895-904. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.